Effectiveness of Domperidone to Increase Breastmilk Supply in Mothers With Low Supply
Launched by HAMILTON HEALTH SCIENCES CORPORATION · Jan 27, 2006
Trial Information
Current as of June 04, 2025
Terminated
Keywords
ClinConnect Summary
Breastfeeding alone, until an infant is 6 months of age, is the best form of infant nutrition. There are many ways to help women breastfeed when they are having difficulties with the process, mostly involving support from a lactation consultant. However, some women, despite all appropriate non-medical interventions and support do not produce sufficient breast milk to meet the nutritional needs of their infant.
This is a feasibility study to determine how domperidone affects breast milk production in women with insufficient milk supply feeding term infants. This project will serve to refine...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women
- • healthy women
- • inadequate milk supply
- • read/speak English
- • Infants
- • healthy term infants (≥ 38 weeks gestational age)
- • age ≥ 2wks and ≤3mths
- • surpassed birth weight
- Exclusion Criteria:
- • Mother
- • cardiac anomalies
- • breast or endocrine abnormalities (i.e. breast CA, pituitary adenomas)
- • medications contraindicated with domperidone use
- • drug or alcohol use
- • use of hormonal contraception
- • Infant
- • physical anomalies making breastfeeding difficult (i.e. cleft palate)
- • cardiac anomalies
About Hamilton Health Sciences Corporation
Hamilton Health Sciences Corporation is a leading healthcare provider in Canada, renowned for its commitment to advancing medical research and improving patient care through innovative clinical trials. With a focus on translating scientific discoveries into effective treatments, the organization operates a network of hospitals and specialized centers that facilitate cutting-edge research across various medical disciplines. Hamilton Health Sciences is dedicated to fostering collaboration among researchers, healthcare professionals, and industry partners, ensuring that clinical trials are conducted with the highest ethical standards and rigor. Through its robust research infrastructure, the corporation aims to enhance health outcomes and contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hamilton, Ontario, Canada
Patients applied
Trial Officials
Katalin Ivanyi, MD
Principal Investigator
McMaster University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials